As we have gained more experience with the use of supraphysiologic doses of LT4 in patients with refractory bipolar disease, it has become apparent that many patients who respond to the adjunctive treatment have serum thyroid hormone levels within normal limits, and have no past history of peripheral thyroid disease. The gene discussed is TG; the disease is thyroid gland disorder.